BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25423695)

  • 21. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
    Jiang T; Huang L; Zhang S
    BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
    Yang J; Tang A; Ma J; Sun X; Ming L
    Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative markers for the prediction of high-risk features in endometrial cancer.
    Panyavaranant P; Manchana T
    World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
    Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion.
    Zhou X; Wang H; Wang X
    J Gynecol Oncol; 2017 Mar; 28(2):e11. PubMed ID: 27894164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of circulating tumour cells may add value in endometrial cancer management.
    Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative serum CA 125 level as a predictor for metastasis and survival in endometrioid endometrial cancer.
    Pinar Cilesiz Goksedef B; Gorgen H; Baran SY; Api M; Cetin A
    J Obstet Gynaecol Can; 2011 Aug; 33(8):844-850. PubMed ID: 21846440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of pretreatment tumor markers in a nomogram model for prognostic prediction of FIGO stage I endometrial cancer: A multi-institutional cohort study.
    Lin H; Wu CH; Ou YC; Huang SW; Fu HC
    Int J Gynaecol Obstet; 2024 Jun; 165(3):1244-1256. PubMed ID: 38287783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
    Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
    Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma.
    Modarres-Gilani M; Vaezi M; Shariat M; Zamani N; Nourizadeh R
    Cancer Biomark; 2017 Aug; 20(2):135-141. PubMed ID: 28800309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
    Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ
    Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
    Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA
    Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer.
    Kemik P; Saatli B; Yıldırım N; Kemik VD; Deveci B; Terek MC; Koçtürk S; Koyuncuoğlu M; Saygılı U
    Gynecol Oncol; 2016 Jan; 140(1):64-9. PubMed ID: 26607777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
    Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer.
    Stokkel LE; van Rossum HH; van de Kamp MW; Boellaard TN; Bekers EM; Kok NFM; van Rhijn BWG; Mertens LS
    Urol Oncol; 2023 Jul; 41(7):326.e17-326.e24. PubMed ID: 36813613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes.
    Anton C; Kleine RT; Mayerhoff E; Diz MDPE; Freitas D; Carvalho HA; Carvalho JPM; Silva ASE; Genta MLND; Silva ALFE; Salim RC; Aranha A; Lopez RVM; Carvalho FM; Baracat EC; Carvalho JP
    PLoS One; 2020; 15(3):e0229543. PubMed ID: 32134921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.